EP
BHVN
Eversept Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-637,139
| Closed | -$96.3M | – | 77 |
|
|
2022
Q3 | $96.3M | Buy |
637,139
+4,345
| +0.7% | +$657K | 8.35% | 1 |
|
|
2022
Q2 | $92.2M | Sell |
632,794
-11,872
| -2% | -$1.73M | 6.56% | 1 |
|
|
2022
Q1 | $76.4M | Buy |
644,666
+329,537
| +105% | +$39.1M | 5.87% | 2 |
|
|
2021
Q4 | $43.4M | Buy |
+315,129
| New | +$43.4M | 2.77% | 8 |
|
|
2021
Q2 | – | Sell |
-242,172
| Closed | -$16.6M | – | 103 |
|
|
2021
Q1 | $16.6M | Buy |
242,172
+138,408
| +133% | +$9.46M | 1.24% | 24 |
|
|
2020
Q4 | $8.89M | Sell |
103,764
-217,817
| -68% | -$18.7M | 1.04% | 25 |
|
|
2020
Q3 | $20.9M | Sell |
321,581
-126,683
| -28% | -$8.24M | 4.65% | 8 |
|
|
2020
Q2 | $32.8M | Buy |
448,264
+341,879
| +321% | +$25M | 4.49% | 4 |
|
|
2020
Q1 | $3.62M | Buy |
+106,385
| New | +$3.62M | 0.9% | 24 |
|